U.S. Physical Therapy, Inc. (NYSE:USPH) Receives $105.33 Average Price Target from Analysts

Shares of U.S. Physical Therapy, Inc. (NYSE:USPH) have received an average rating of “Moderate Buy” from the seven analysts that are covering the company, Marketbeat reports. Three equities research analysts have rated the stock with a hold recommendation and four have issued a buy recommendation on the company. The average 12-month price objective among analysts that have issued ratings on the stock in the last year is $105.3333.

Several equities analysts have recently commented on the stock. Weiss Ratings reaffirmed a “hold (c)” rating on shares of U.S. Physical Therapy in a research report on Wednesday, January 21st. Barrington Research reaffirmed an “outperform” rating and set a $103.00 target price on shares of U.S. Physical Therapy in a report on Monday, January 5th. Citigroup reiterated a “market outperform” rating on shares of U.S. Physical Therapy in a report on Monday, December 15th. Finally, JPMorgan Chase & Co. dropped their price target on U.S. Physical Therapy from $110.00 to $100.00 and set an “overweight” rating on the stock in a research report on Monday, November 24th.

U.S. Physical Therapy Stock Down 0.2%

Shares of NYSE:USPH opened at $86.33 on Monday. The firm has a market cap of $1.31 billion, a PE ratio of 36.27, a price-to-earnings-growth ratio of 3.57 and a beta of 1.30. The company has a fifty day simple moving average of $83.09 and a 200 day simple moving average of $82.34. The company has a current ratio of 1.20, a quick ratio of 1.20 and a debt-to-equity ratio of 0.30. U.S. Physical Therapy has a 12-month low of $62.77 and a 12-month high of $93.50.

Institutional Investors Weigh In On U.S. Physical Therapy

Institutional investors have recently modified their holdings of the business. Envestnet Asset Management Inc. increased its holdings in shares of U.S. Physical Therapy by 9.4% during the second quarter. Envestnet Asset Management Inc. now owns 346,160 shares of the company’s stock valued at $27,070,000 after purchasing an additional 29,671 shares during the period. Allspring Global Investments Holdings LLC acquired a new stake in U.S. Physical Therapy in the third quarter worth about $845,000. Geode Capital Management LLC grew its position in U.S. Physical Therapy by 1.2% in the 2nd quarter. Geode Capital Management LLC now owns 352,923 shares of the company’s stock valued at $27,602,000 after buying an additional 4,306 shares in the last quarter. Bank of New York Mellon Corp increased its stake in U.S. Physical Therapy by 4.9% during the 2nd quarter. Bank of New York Mellon Corp now owns 131,556 shares of the company’s stock valued at $10,288,000 after buying an additional 6,190 shares during the period. Finally, CenterBook Partners LP increased its stake in U.S. Physical Therapy by 189.0% during the 2nd quarter. CenterBook Partners LP now owns 47,014 shares of the company’s stock valued at $3,676,000 after buying an additional 30,746 shares during the period.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc (NYSE: USPH) is a leading owner and operator of outpatient physical therapy clinics across the United States. The company delivers rehabilitative care to patients recovering from orthopedic injuries, neurological disorders and chronic conditions. Its core services include one-on-one physical therapy sessions, aquatic therapy, occupational therapy, massage therapy and sports medicine programs designed to restore mobility and enhance quality of life.

In addition to traditional rehabilitation services, U.S.